What is the antidote for amitriptyline toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antidote for Amitriptyline Toxicity

Sodium bicarbonate is the primary antidote for amitriptyline toxicity, administered as 50-150 mEq IV bolus in adults (1-3 mEq/kg in children) to treat life-threatening cardiotoxicity including QRS prolongation, ventricular dysrhythmias, and hypotension. 1

Primary Treatment: Sodium Bicarbonate

Amitriptyline is a tricyclic antidepressant (TCA) that acts as a sodium channel blocker in overdose. The 2023 American Heart Association guidelines provide Class 1, Level B-NR recommendation for sodium bicarbonate as the definitive antidote for TCA-induced cardiotoxicity 1.

Dosing and Administration

  • Adult dose: 50-150 mEq IV/IO bolus 1
  • Pediatric dose: 1-3 mEq/kg IV/IO bolus 1
  • Continuous infusion: Prepare 150 mEq/L solution, infuse at 1-3 mL/kg/h 1
  • Target serum pH: 7.45-7.55 2

Mechanism and Monitoring

The therapeutic goal is both sodium loading and alkalinization. A maximal limb-lead QRS duration ≥0.10 seconds is the best indicator of overdose severity 2. If pH response is inadequate, hyperventilation may be added with extreme caution and frequent pH monitoring. Avoid pH >7.60 or pCO₂ <20 mmHg 2.

Critical monitoring parameters: Watch for hypernatremia, alkalemia, hypokalemia, and hypochloremia 1.

Supportive Management

Gastrointestinal Decontamination

All suspected TCA overdoses require large-volume gastric lavage followed by activated charcoal 2. Emesis is contraindicated 2. If consciousness is impaired, secure the airway before lavage.

Seizure Control

Administer benzodiazepines as first-line treatment for seizures 2. If ineffective, use phenobarbital or phenytoin. Physostigmine is NOT recommended except for life-threatening symptoms unresponsive to other therapies, and only in consultation with poison control 2.

Cardiac Monitoring

A minimum of 6 hours of cardiac monitoring is mandatory, with extended monitoring if any signs of toxicity appear 2. Patients have succumbed to fatal dysrhythmias late after overdose, emphasizing the need for prolonged observation.

Dysrhythmias Refractory to Bicarbonate

If sodium bicarbonate/hyperventilation fails, consider lidocaine, bretylium, or phenytoin 2. Type 1A and 1C antiarrhythmics (quinidine, disopyramide, procainamide) are contraindicated 2.

Controversial/Emerging Therapies

Intravenous Lipid Emulsion (ILE)

While ILE has been used in case reports for amitriptyline toxicity 3, 4, there is no guideline support for its routine use. The evidence shows mixed results, with one case reporting delayed toxicity and iatrogenic pancreatitis from ILE 3. Another case showed no dramatic hemodynamic improvement despite prolonged infusion 4. ILE should only be considered in consultation with toxicology for refractory cardiac arrest.

VA-ECMO

For refractory cardiogenic shock unresponsive to maximal pharmacological therapy, VA-ECMO may be lifesaving 1. This is a Class 2a recommendation based on case series showing survival even after cardiac arrest.

Common Pitfalls

  1. Delayed toxicity: Signs develop rapidly but can also appear late. Never discharge based on initial stability alone 2.
  2. Inadequate monitoring duration: Minimum 6 hours required, extended if any toxicity signs 2.
  3. Using contraindicated antiarrhythmics: Avoid Type 1A/1C agents which worsen sodium channel blockade 2.
  4. Plasma level monitoring: Should NOT guide management 2.
  5. Hemodialysis: Generally ineffective for TCA poisoning 2.

Clinical Manifestations to Recognize

Critical signs include: cardiac dysrhythmias, severe hypotension, convulsions, CNS depression/coma, QRS prolongation, rightward terminal QRS axis shift, prolonged QT interval, sinus tachycardia, impaired myocardial contractility, dilated pupils, confusion, agitation, and muscle rigidity 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.